Wall Street Thinks Chemours Company (CC) Is Too Cheap To Ignore Now

The Chemours Company (NYSE:CC) is one of the 8 Most Undervalued Growth Stocks to Buy for the Next 10 Years. According to a report released on July 6, BMO Capital analyst John McNulty reiterated a Buy rating on The Chemours Company (NYSE:CC) with a price target of $26. The firm’s assigned price target is close to the median Wall Street analysts’ price target of $25, according to 11 analysts covering the stock. Moreover, the stock is currently trading about 11% below the lowest Wall Street price target of $21.

In contrast to BMO Capital, Mizuho Securities cut its price target on The Chemours Company (NYSE:CC) from $30 to $25 while keeping its Outperform rating on July 1. The firm’s downward-adjusted price target still presents a further 32% upside from current levels. Mizuho Securities updated its outlook for the chemical sector as part of its second-quarter earnings preview. The firm lowered price targets for most basic chemical companies.

According to Mizuho Securities, the recent decline in oil prices has reduced the expected cost advantage of natural gas for many basic chemical producers. At the same time, the firm believes that continued investment in advanced computing infrastructure will support demand for technology materials over the longer term.

The Chemours Company (NYSE:CC) is a global specialty chemicals company. The company operates in the Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials segments. It is based in Wilmington, Delaware, and serves customers worldwide.

READ NEXT: 10 Best AI Stocks to Watch in July and 12 Best Dow Stocks to Invest In Right Now.

Disclosure: None. Follow Insider Monkey on Google News.